Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 13
NanoString Technologies To Raise US$0.65 Million In Venture Financing 15
Partnerships 16
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 17
NanoString Enters into Co-Development Agreement with Celgene 18
NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 19
Licensing Agreements 20
NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 20
Equity Offering 21
NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 21
NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 23
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 24
NanoString Technologies Completes IPO Of Shares For US$54 Million 26
NanoString Technologies Inc – Key Competitors 28
NanoString Technologies Inc – Key Employees 29
NanoString Technologies Inc – Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Financial Announcements 31
Aug 07, 2018: NanoString Technologies Releases Operating Results for Second Quarter of 2018 31
Jul 16, 2018: NanoString Technologies Provides Preliminary Revenue Results for Second Quarter 2018 33
May 08, 2018: NanoString Technologies Releases Operating Results for First Quarter of 2018 34
Jan 08, 2018: NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017 36
Nov 02, 2017: NanoString Technologies Releases Operating Results for Third Quarter of 2017 37
Oct 11, 2017: NanoString Announces Preliminary Revenue for Third Quarter of Fiscal Year 2017 38
Aug 08, 2017: NanoString Technologies Releases Operating Results for Second Quarter of 2017 39
May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 40
Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 41
Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 42
Corporate Communications 43
May 10, 2017: NanoString Appoints Elisha W. Finney to Board of Directors 43
Product News 44
Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 44
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 13
NanoString Technologies To Raise US$0.65 Million In Venture Financing 15
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 17
NanoString Enters into Co-Development Agreement with Celgene 18
NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 19
NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 20
NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 21
NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 23
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 24
NanoString Technologies Completes IPO Of Shares For US$54 Million 26
NanoString Technologies Inc, Key Competitors 28
NanoString Technologies Inc, Key Employees 29
List of Figures
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10